Iclusig 15 MG
Ended Awarded
- Contract number
- 36C24525N0161
- Awardee
-
Takeda Pharmaceuticals America, Inc. UEI ENNFDLWFC6L1
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $13,957
Award facts
- Contract value 100% obligated
- $13,956.72 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Earth City, MO 63045, USA
Award details come from SAM.gov/FPDS.
About this award
The U.S. Department of Veterans Affairs (VA) awarded a $13,956.72 firm-fixed-price delivery order contract to Takeda Pharmaceuticals America, Inc. for the supply of ICLUSIG 15 MG, a specialty oncology medication. This order was placed against Takeda's General Services Administration (GSA) Schedule 61-IB for Pharmaceuticals and Drugs and supports the VA's procurement of critical drugs for its nationwide network of medical facilities. The contract has an ultimate completion date of November 11, 2024 and was awarded on November 6, 2024. Takeda Pharmaceuticals America, Inc. is a foreign-owned, for-profit manufacturer of pharmaceutical products that specializes in providing oncology drugs to the VA. This order is part of Takeda's larger $123.5 million Blanket Purchase Agreement with the VA National Acquisition Center for the supply of ICLUSIG, which was recently renewed in October 2024.
Quick answers
Who was awarded contract 36C24525N0161?
36C24525N0161 was awarded to Takeda Pharmaceuticals America, Inc. by Veterans Integrated Service Network 5 (Veterans Health Administration) on November 6, 2024.
How much is contract 36C24525N0161 worth?
The government has obligated $13,957 on 36C24525N0161.
Is contract 36C24525N0161 an order under another contract?
Yes. 36C24525N0161 is a delivery order under 36F79718D0586, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24525N0161 competed?
The extent of competition for 36C24525N0161 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award